TGFβ and BMPs pathways can contribute to the synergistic suppression of tumor growth, but atypical TGFβ that activates PI3K/AKT signaling can reverse this suppression and promote tumor cell proliferation [30]. The gene discussed is AKT1; the disease is neoplasm.